PolyActiva Pty Ltd.
PolyActiva is an innovative clinical-stage ophthalmology company with a unique proprietary polymeric prodrug technology that enables site-specific, precise and controlled drug delivery to the eye. Our mission is to become a leader in ophthalmic medicine by providing unique biodegradable implants with sustained drug delivery to improve patient outcomes and quality of life. The polymeric prodrugs can take various forms, including rod-shaped implants, injectable gels and topical films and the rate of drug delivery can be controlled for up to 12 months. All of the products are designed to biodegrade after the treatment period, leaving no residue. As a consequence, PolyActiva`s delivery technology is very well suited to drug delivery at sites of the body that have limited volumes
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Nationally (across the country)
About Us
The technology enables products with high dose loads, which means sufficient drug can be carried in products of a very small size and still deliver therapeutic daily doses to the therapeutic site over extended periods.
With the PolyActiva technology, exceptional zero-order release profiles are achieved over treatment periods ranging from 1 to 12 months.
PolyActiva has secured a world-class team of more than 10 staff that provide the core chemistry and development capabilities. We have also established solid relationships with key research service providers, who provide capabilities in pharmaceutical chemistry, polymer chemistry, ophthalmology and commercialisation.